The present invention is related to isolated mitochondria for use in the treatment and/or prevention of Alzheimer's disease, and/or for use in the improvement of memory deficits and/or learning impairments of a subject, and/or for use in the reduction in a concentration of β-amyloid peptides in a cell of a subject.